{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-26-000009","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2026-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.369533+00:00","generated_at":"2026-05-16T10:12:09.313937+00:00","sec_items":["5.07","8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GRI Bio shareholders approve reverse stock split; company addresses Nasdaq equity deficiency with $8M offering","bullets":["Shareholders approved reverse stock split at ratio between 1:2 and 1:30, with board discretion to set exact ratio or abandon.","Company received Nasdaq deficiency notice on Nov 26, 2025 for stockholders' equity below $2.5M.","Dec 12, 2025 public offering raised ~$8.0M gross proceeds, bringing equity above the $2.5M minimum.","Nasdaq will monitor compliance at next periodic report; failure may lead to delisting."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-26-000009","json":"https://secwatch.observer/filing/0001824293-26-000009.json","markdown":"https://secwatch.observer/filing/0001824293-26-000009.md","text":"https://secwatch.observer/filing/0001824293-26-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000009/0001824293-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000009/val-20260115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:12:09.313937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}